Results 101 to 110 of about 2,049,710 (211)

Cutaneous gene therapy

open access: yesAnnals of Medicine, 2007
Possibilities of using the skin for somatic gene therapy have been investigated for more than 20 years. Strategies have included both direct gene transfer into the skin and indirect gene transfer utilizing cultured cells as an intermediate step for gene manipulation.
openaire   +3 more sources

Gene therapy targeting SARM1 blocks pathological axon degeneration in mice [PDF]

open access: yes, 2019
Axonal degeneration (AxD) following nerve injury, chemotherapy, and in several neurological disorders is an active process driven by SARM1, an injury-activated NADase.
DiAntonio, Aaron   +8 more
core   +1 more source

Liver fibrosis negatively impacts in vivo gene transfer to murine hepatocytes

open access: yesNature Communications
Liver fibrosis occurs in several genetic and acquired disease conditions, leading to alterations of the tissue and metabolism, which may adversely affect viral vector-mediated gene therapy.
Chiara Simoni   +12 more
doaj   +1 more source

Rational engineering of microRNA-regulated viruses for cancer gene therapy [PDF]

open access: yes, 2013
MicroRNAs (miRNAs) are small noncoding RNA molecules that have important regulatory roles in a wide range of biological processes. miRNAs are often expressed in a tissue- and/or differentiation state-specific patterns, and it is estimated that miRNAs can
Ylösmäki, Erkko
core  

Gene Therapy for Heart Failure. [PDF]

open access: yesJ Cardiovasc Transl Res
Wang H, Määttä A, Ylä-Herttuala S.
europepmc   +1 more source

Hematopoietic Stem-Cell Gene Therapy for Cystinosis. [PDF]

open access: yesN Engl J Med
Barshop BA   +19 more
europepmc   +1 more source

Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy. [PDF]

open access: yesTransplant Cell Ther
Sharma A   +19 more
europepmc   +1 more source

P1386: USE OF A FOAMY-VIRUS VECTOR SYSTEM TO PRODUCE AN ‘OFF-THE-SHELF’ FCΓ-CR-T CELL PRODUCT FOR THE TREATMENT OF HEMATOLOGICAL AND SOLID TUMOR MALIGNANCIES

open access: yesHemaSphere, 2023
Ioanna Lazana   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy